Description
| Strength | 100mg |
| Brand Name | N Dula |
| Manufacturer | Intelico Pharmaceuticals Pvt Ltd |
| Packaging Type | Box |
| Usage/Application | Empiric Antifungal Therapy In Febrile Neutropenia (Off-label) |
| Shelf Life | 24 Months |
| Composition | Anidulafungin |
| Form | Injection |
Product’s Details:
- N Dula 100 mg (Anidulafungin Injection) is a broad-spectrum antifungal medication belonging to the echinocandin class. It is highly effective against Candida species, including strains resistant to azoles, and is indicated for serious fungal infections such as candidemia, invasive candidiasis, and esophageal candidiasis. It is also used off-label as empiric antifungal therapy in febrile neutropenia. Anidulafungin works by inhibiting β-(1,3)-D-glucan synthesis, an essential component of the fungal cell wall, leading to cell death.
- Composition: Each vial contains 100 mg of Anidulafungin for intravenous infusion.
- Indications / Uses:
- Candidemia (fungal infection in the bloodstream)
- Invasive candidiasis
- Esophageal candidiasis
- Empiric antifungal therapy in febrile neutropenia (off-label)
- Features & Benefits:
- Effective against Candida species, including resistant strains
- Suitable for systemic and invasive fungal infections
- Reliable option when azole antifungals are ineffective
- Well-tolerated with low drug interaction potential
- Recommended in both adult and critically ill patients
-
Side Effects: Common side effects may include:
- Hypokalemia
- Nausea, diarrhea
- Rash or flushing
- Elevated liver enzymes
- Storage:
- Store dry vials at 2–8°C (refrigerated)
- Protect from light
- After reconstitution and dilution, use within 24 hours if refrigerated (2–8°C)
Reviews
There are no reviews yet.